Eye on FDA
RX for Pharma Industry Communications and Planning
Skip to content
  • Social/Digital Media and FDA
  • Speaking Engagements
← The Importance of Being Washington – The GAO Outlines FDA Reforms
MedReg Wins the Battles, Loses the War →

Morningstar on the Wyeth/Pfizer News

Posted on January 26, 2009 by Mark Senak

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
This entry was posted in Business/Industry News. Bookmark the permalink.
← The Importance of Being Washington – The GAO Outlines FDA Reforms
MedReg Wins the Battles, Loses the War →
  • About the Author

    Mark Senak
    My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market.
    • More About Me and the Blog
    • Follow Me on Twitter
    • My Videos and Podcasts
    • Books by Me
  • Stay Connected

    • Subscribe via Email
    • Contact Me
    • Twitter
    • RSS
  • My Profile

    I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!
  • About This Blog

    Eye on FDA is published by Mark Senak of FleishmanHillard's Washington, D.C. office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
  • Posts by Date

    January 2009
    M T W T F S S
     1234
    567891011
    12131415161718
    19202122232425
    262728293031  
    « Dec   Feb »
  • My Favorite Dogs

    6a00d83451bf5969e200e54f62616f8834-500wi 6a00d83451bf5969e200e54f626c908834-500wi 6a00d83451bf5969e200e54f6594488834-500wi 6a00d83451bf5969e200e54f65949b8834-500wi 6a00d83451bf5969e200e54f6aa3be8833-500wi 6a00d83451bf5969e200e54f6e677a8834-500wi
  • Twitter List

    • FDA Tweets
    • Government Health Agencies on Twitter
    • Medical Journals on Twitter
    • Pharma Companies on Twitter
    • Reporters on Twitter
  • Legislative Tracking Tools

    • Congress.gov
    • GovTrack: Your Settings
    • Open Congress
    • Open States (State Legislation Tracking Tool)
  • RSS

    Subscribe to Eye on FDA by Email
  • Books by Me

    • Mark S. Senak: A Fragile Circle: A MemoirMark S. Senak: A Fragile Circle: A Memoir
    • Mark S. Senak: HIV, AIDS, and the Law: A Guide to Our Rights and Challenges Mark S. Senak: HIV, AIDS, and the Law: A Guide to Our Rights and Challenges
    • 
Mark S. Senak: Every Trick in the Book : The Essential Gay and Lesbian Legal Guide Mark S. Senak: Every Trick in the Book : The Essential Gay and Lesbian Legal Guide
Eye on FDA
Proudly powered by WordPress.